Patient: Page 19
-
PharmaVoice Team/PharmaVoice
Speak Out
Understanding The Why Applying health psychology to deliver effective patient support As a health and clinical psychologist, I’ve spent the last ten years helping the healthcare industry address the self-management needs of patients living with long-term conditions. For the most part, this work h...
By Kate Perry • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Riding the AI Wave It would be hard to identify a hotter trend right now than artificial intelligence and machine learning — a trend 60 years in the making since John McCarthy coined the term AI while leading a Dartmouth Summer Research Project. Merriam-Webster defines AI as: a branch of computer...
By Taren Grom • May 1, 2018 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
HBA Rising Stars & Luminaries: Leadership and Vision
PharmaVOICE tapped the nearly 100 industry executives identified by their companies as HBA Rising Stars and Luminaries to identify the biggest trends they believe will impact the industry in the next few years. Top on their list are digital and technology solutions, disruption, and innovation. Th...
By PharmaVoice Team • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Getting personal There’s a pretty good chance that everyone reading this special issue — Patients’ Voices — is either a patient, a caregiver to a patient, or knows someone who has been diagnosed with a chronic or acute condition. But just because we are all patients or know a patient doesn’t mean...
By Taren Grom • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Patients and Health Literacy
What people know about health and healthcare and what they do with that knowledge has a major impact on their health and well-being. When patients are given health information in a way they can understand, they tend to make better health decisions. Low health literacy, on the other hand, is a con...
By Denise Myshko • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Patient Journeys And Storytelling
Real life patient stories started seeping into the pharma lexicon well over a decade ago, on both a commercial and research level. The industry began turning to end users to discover how to create better drug delivery processes, clinical trial protocols, and marketing efforts, as well as to accur...
By Robin Robinson • April 1, 2018 -
PharmaVoice Team/PharmaVoice
The Changing Role of Patient Advocacy
The role of patient advocacy is a broad one — from supporter, to sponsor, to campaigner, to spokesperson and beyond. Indeed, patient advocacy means different things to different stakeholders, says Keri McDonough, senior team leader, Biosector 2, a Syneos Health company. “When patient advocacy gro...
By Kim Ribbink • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Executive Perspective: The Lens of Health Psychology
As chronic illness continues to dominate the healthcare landscape, more and more people are being charged with taking active roles in managing their condition and treatment. Laura Moore, Ed.D., CHES, Lead Health Psychology Specialist at Atlantis Healthcare, believes the field of health psychology...
By Laura Moore • April 1, 2018 -
PharmaVoice Team/PharmaVoice
Moving Beyond the "Beyond the Pill" Conversation
The pursuit of better outcomes from all sides of the healthcare equation is driving the creation of more and more digital treatments and supplemental services as drug companies strive to prove, and increase, the value of their drugs — to payers, physicians, and patients. The value-add of these di...
By Robin Robinson • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Behavioral Economics
Have you ever made a decision — health or otherwise — and on reflection, you couldn’t be sure what drove you to make it? That’s called being human. It’s that characteristic — making decisions based on emotions or gut instinct rather than logic — that is at the heart of behavioral economics. To su...
By Robin Robinson • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
How Well Do You Really Know Your Patients?
Why an outsourcing evolution builds better patient relationships Global Genes reports that therapy adherence in the rare disease space can vary from only 58% to 65%, a troubling statistic for our industry, and most importantly, the patients we serve. Manufacturers must be wondering, how well do w...
By Linda Newberry-Ferguson • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
The Value of Online Support Groups in Rare Disease Communities - and the Role Pharma Marketers Can Play
Online support groups for patients and caregivers living with rare diseases have grown tremendously in number and size over the past 10 years. Often closed to the general public, these semi-private groups are usually started by one or two motivated individuals, then extend throughout the world to...
By Laurie Bartolomeo • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
Commercialization Strategies in Rare Diseases
Agency Partners Simply Can’t Fake It. Over the course of my career working in pharmaceutical advertising, one of the most common refrains I’ve heard through the years from eager agency folks is: “We need to get into oncology or rare diseases." I have to admit that it’s a declaration that always m...
By David M. Paragamian • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
A Patient-Focused Approach to Rare Diseases - Connecting with Multiple Stakeholders
In order to successfully commercialize a rare disease product, manufacturers must consider the needs of multiple stakeholders. Adding to the challenge, each stakeholder may have unique needs. This creates increased complexity when marketing a therapy in the rare disease space, but also offers mul...
By David Schneider • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
Last Word
Supporting Caregivers Scott Williams, VP, Head of Global Patient Advocacy and Strategic Partnerships, EMD Serono, talks about the company’s efforts to recognize and support unpaid caregivers. PV: What is the Embracing Carers program and EMD Serono’s role? Williams: Embracing Carers is a global m...
By Scott Williams • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Red Zone: Applying User Experience Design to Develop Effective Patient Suport
Treatment nonadherence is a complex behavior that requires much more than a simple one-size-fits-all approach to address the challenge. What can pharma learn from the behavioral sciences to deliver patient support that is effective in improving tx adherence? Health psychology and behavioral econo...
By Kate Perry • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Upfront
Pfizer Service Provides Social Workers for Patients Pfizer Oncology Together is a first-of-its-kind offering for patients taking Pfizer Oncology medicines. The program offers dedicated social workers called “Care Champions" to help navigate the complexities that accompany treatment, such as ident...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
HealthTech
LivaNova Receives FDA Approvals for SenTiva Device for Treatment of Epilepsy Trend Watch: Health Technology Increases Wellness Across Epilepsy, Autism, and Weight Loss LivaNova, a market-leading medical technology company, has received FDA approval for its latest vagus nerve stimulation therapy (...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Last Word
Digital Health Initiatives Georgia Mitsi, Senior Director, Search Evaluation & Digital Health Care Initiatives, at Sunovion Pharmaceuticals, discusses the company’s digital health efforts. PV: What is the driving force behind the many digital health initiatives at Sunovion? Mitsi: Sunovion’s ...
By Georgia Mitsi • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: What Does the Future Hold?
We tasked the PharmaVOICE 100 community of industry executives to think about some of the most important trends they expect will challenge the status quo, move the industry forward, and contribute to breakthroughs in medicine and business models. Their thoughtful insights signal the multitude of ...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Pipeline Disrupters
In recent years, several therapeutic disruptors have hit the market, pushing aside current standard treatment protocols. From hepatitis C cures to immuno-oncology therapies, recent approvals have upended how diseases are treated, providing patients with significant advances. Pharmaceutical, biote...
By PharmaVoice Team • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Treatment to Wellness
Attitudes about treating disease are undergoing a fundamental shift as the life-sciences industry faces pressure to demonstrate value. Increasingly, there is a move from treatment to prevention, diagnostics and cure, which KPMG says is leading to the rise of new competitors. By 2030, practitioner...
By Kim Ribbink • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: Healing Patients With Digital Warmth: A Prescription for Life Sciences
Earlier this year, ReD Associates and Cognizant conducted an extensive research that cut across disease areas to understand how patients heal – that is, what happens when people face a health risk or issue and need to manage or overcome it. By participating in people’s everyday lives, we found th...
By Bhaskar Sambasivan • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: safety portal: Increasing Patient Safety While Reducing Cost and Complexity
Although it sounds straightforward, global safety reporting of clinical trial adverse events is complicated, time-consuming and extremely expensive. Despite the substantial investment of time and money, research shows that global safety reporting is not protecting patients as well as it could. Dr...
By Steven Beales • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Patient Solutions: Responding to the Needs of the Savvy Patient
Responding to the Needs of the Savvy Patient When healthcare IT strategist Leonard Kish referred to patient engagement as the blockbuster drug of the century, he tapped into an important realization: that the patient has to be at the center of everything a pharmaceutical company does. Today’s pat...
By PharmaVoice Team • Oct. 1, 2017
Previous
